Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Quadrivalent Influenza Virus Vaccine”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02519855
What this trial is testing

Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 882
Post-approval studies (Phase 4)Study completedNCT05471531
What this trial is testing

Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine

Who this might be right for
Influenza and Pneumonia
Sinovac Biotech Co., Ltd 3,000
Early research (Phase 1)Study completedNCT04451954
What this trial is testing

Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects

Who this might be right for
Influenza ImmunisationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 210
Post-approval studies (Phase 4)Study completedNCT05313893
What this trial is testing

A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years

Who this might be right for
Influenza
Jiangsu Province Centers for Disease Control and Prevention 252
Large-scale testing (Phase 3)Study completedNCT01240746
What this trial is testing

Study of Quadrivalent Influenza Vaccine Among Children

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 4,363
Early research (Phase 1)Study completedNCT05212623
What this trial is testing

A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months

Who this might be right for
Influenza
Jiangsu Province Centers for Disease Control and Prevention 120
Large-scale testing (Phase 3)Study completedNCT05062759
What this trial is testing

Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma

Who this might be right for
Moderate to Severe Asthma
AstraZeneca 70
Testing effectiveness (Phase 2)UnknownNCT02434276
What this trial is testing

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

Who this might be right for
Influenza
VaxInnate Corporation 450
Large-scale testing (Phase 3)Study completedNCT00860067
What this trial is testing

Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age

Who this might be right for
Healthy or Stable Underlying Chronic Medical Condition
MedImmune LLC 1,800
Early research (Phase 1)Study completedNCT02269007
What this trial is testing

A Phase I Clinical Trial for Inactivated Quadrivalent Influenza Vaccine (Split Virion) in Healthy Adults in China

Who this might be right for
Influenza
Jiangsu Province Centers for Disease Control and Prevention 110
Large-scale testing (Phase 3)Study completedNCT03765437
What this trial is testing

Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in Vietnam

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 230
Large-scale testing (Phase 3)Study completedNCT02914275
What this trial is testing

Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.

Who this might be right for
Influenza, Human
Seqirus 2,250
Testing effectiveness (Phase 2)Study completedNCT06361875
What this trial is testing

Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 908
Not applicableStudy completedNCT02148211
What this trial is testing

Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry

Who this might be right for
Influenza
GlaxoSmithKline 507
Post-approval studies (Phase 4)Study completedNCT06141655
What this trial is testing

HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia

Who this might be right for
Influenza
Federico Martinón Torres 134,476
Large-scale testing (Phase 3)Study completedNCT02352584
What this trial is testing

A Multicenter, Double-blind, Parallel Phase III Study

Who this might be right for
Influenza
Green Cross Corporation 1,299
Not applicableStudy completedNCT05078060
What this trial is testing

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2021/22

Who this might be right for
Influenza (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 1,804
Testing effectiveness (Phase 2)Study completedNCT04363359
What this trial is testing

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine

Who this might be right for
Influenza
Shanghai Institute Of Biological Products 1,980
Not applicableStudy completedNCT01985997
What this trial is testing

Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age

Who this might be right for
Observation Safety
MedImmune LLC 95,000
Post-approval studies (Phase 4)Study completedNCT02743117
What this trial is testing

Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2016-2017 Season

Who this might be right for
InfluenzaHealthy
MedImmune LLC 301
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation